Earnings Outlook For Oncternal Therapeutics
Portfolio Pulse from Benzinga Insights
Oncternal Therapeutics (NASDAQ:ONCT) is set to release its latest quarterly earnings report on November 9, 2023. Analysts estimate an earnings per share (EPS) of $-0.14. The company's stock performance has been generally negative over the last 52-week period, with shares down 62.53%. Last quarter, the company beat EPS by $0.01, which was followed by a 7.35% drop in the share price.
November 08, 2023 | 6:02 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Oncternal Therapeutics is expected to report an EPS of $-0.14. The company's shares have been on a downward trend, decreasing by 62.53% over the past year.
The company's stock has been on a downward trend, and even though it beat the EPS estimate last quarter, the share price still dropped. This suggests that investors may have low confidence in the company's financial performance, which could continue to put downward pressure on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100